Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
Division of Gynecologic Oncology, Fondazione "Policlinico Universitario A. Gemelli", Catholic University of the Sacred Heart, Rome, Italy.
Eur J Surg Oncol. 2018 Jun;44(6):754-759. doi: 10.1016/j.ejso.2018.01.092. Epub 2018 Feb 13.
This study aims at evaluating the feasibility, surgical outcome and oncological results observed after robotic radical hysterectomy (RH) compared to laparoscopy for patients with early stage cervical cancer (ECC) patients.
Between January 2010 and October 2016, 210 patients underwent RH for treatment of ECC: 70 underwent robotic approach (Cases), and 140 underwent laparoscopic approach (Controls).
There was no statistically significant difference between the two approaches with regard to clinical patient characteristics and in terms of extent of RH and rate of pelvic and aortic lymphadenectomy. Operative time was significantly longer in the robotic versus laparoscopic group (median = 243 min, range 90-612 versus median = 210 min, range 80-660; p value = 0.008). Conversion to laparotomy was necessary in 4 patients (1.9%) in the whole series. No difference was found in terms of intraoperative and postoperative complications between the two groups. Overall, during the observation period, 34 (16.2%) patients experienced any grade postoperative complications, and 21 (10.0%) had >G2 complications. The 3-yr DFS was 88.0% versus 84.0% in robotic and laparoscopic group, respectively (p value = 0.866). Central and/or lateral pelvic disease represented the most common site of relapse. The 3-yr OS was 90.8% in patients underwent robotic RH versus 94.0% in patients underwent laparoscopic RH (p value = 0.924).
The present study shows the equivalence of robotic and laparoscopic approaches to radical surgery of ECC patients, in terms of perioperative and postoperative outcomes with equivalent survival figures, and thus the choice of approach can be tailored to the choice of patient and surgeon.
本研究旨在评估机器人根治性子宫切除术(RH)与腹腔镜治疗早期宫颈癌(ECC)患者的可行性、手术结果和肿瘤学结果。
2010 年 1 月至 2016 年 10 月,210 例患者接受 RH 治疗 ECC:70 例采用机器人方法(病例组),140 例采用腹腔镜方法(对照组)。
两组患者的临床特征和 RH 范围以及盆腔和主动脉淋巴结清扫率无统计学差异。机器人组的手术时间明显长于腹腔镜组(中位数=243 分钟,范围 90-612 与中位数=210 分钟,范围 80-660;p 值=0.008)。整个系列中有 4 例(1.9%)需要转为剖腹手术。两组术中及术后并发症无差异。总的来说,在观察期间,34 例(16.2%)患者出现任何级别的术后并发症,21 例(10.0%)患者出现>G2 并发症。机器人组和腹腔镜组的 3 年 DFS 分别为 88.0%和 84.0%(p 值=0.866)。中央和/或侧盆腔疾病是复发最常见的部位。接受机器人 RH 的患者 3 年 OS 为 90.8%,接受腹腔镜 RH 的患者为 94.0%(p 值=0.924)。
本研究表明,在围手术期和术后结果方面,机器人和腹腔镜方法治疗 ECC 患者的根治性手术具有等效性,具有等效的生存数据,因此可以根据患者和外科医生的选择来选择手术方法。